Junichi Yasui
Nagasaki University
8 Papers
75 Citations
Junichi Yasui is an academic researcher from Nagasaki University. The author has contributed to research in topics: Diabetes mellitus & Thyroglobulin. The author has an hindex of 4, co-authored 7 publications.
Chat about Author
Papers
Putative IgG4-related pituitary disease with hypopituitarism and/or diabetes insipidus accompanied with elevated serum levels of IgG4.
Ai Haraguchi,Ai Era,Junichi Yasui,Takao Ando,Ikuko Ueki,Ichiro Horie,Misa Imaizumi,Toshiro Usa,Kuniko Abe,Tomoki Origuchi,Katsumi Eguchi +10 more
TL;DR: In order to make a correct diagnosis of pituitary lesion involvement with IgG4-related disease, the clinical background and concomitant disorders should be carefully taken into consideration and the measurement of serum levels of IgG 4 seems to be useful.
Non-specific activities against ruthenium crosslinker as a new cause of assay interference in an electrochemilluminescent immunoassay.
Takao Ando,Junichi Yasui,Naoko Inokuchi,Toshiro Usa,Kiyohito Ashizawa,Shimeru Kamihara,Katsumi Eguchi +6 more
TL;DR: Three cases shown clinical data of thyroid function influenced by new type of assay interference are reported, which shows how each assay works, and how and when the assay is non-specifically influenced.
30
Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan
Junichi Yasui,Eiji Kawasaki,Shoichiro Tanaka,Takuya Awata,Hiroshi Ikegami,Akihisa Imagawa,Yasuko Uchigata,Haruhiko Osawa,Hiroshi Kajio,Yumiko Kawabata,Akira Shimada,Kazuma Takahashi,Kazuki Yasuda,Hisafumi Yasuda,Toshiaki Hanafusa,Tetsuro Kobayashi +15 more
TL;DR: The NIR-SPIDDM patients showed later diabetes onset, higher body mass index, longer duration before diagnosis, and less frequent hyperglycemic symptoms at onset, which must be carefully considered in planning prevention trials for SPIDDM.
Sequential elevation of autoantibodies to thyroglobulin and glutamic acid decarboxylase in type 1 diabetes.
Eiji Kawasaki,Junichi Yasui,Masako Tsurumaru,Haruko Takashima,Toshiyuki Ikeoka,Fumi Mori,Satoru Akazawa,Ikuko Ueki,Masakazu Kobayashi,Hironaga Kuwahara,Norio Abiru,Hironori Yamasaki,Atsushi Kawakami +12 more
TL;DR: A 32-year-old Japanese female with a thirteen-year history of type 1 diabetes whose levels of GAD65A were elevated just after the emergence of anti-thyroid autoimmunity is described.
7
Subacute thyroiditis in a patient with psoriatic arthritis switched from secukinumab to adalimumab: a case report and literature review
Jun Nakagawa,K. Fujikawa,Midori Akagi,Keita Nakaji,Junichi Yasui,Yumi Hanatani,Toshihide Hara,Akinari Mizokami,Atsushi Kawakami +8 more
- 02 Jan 2021
TL;DR: Following the administration of ixekizumab, an IL-17A inhibitor, her PsA improved without SAT relapse, and SAT mechanism associated with TNF inhibitors remains unknown, but cytokine imbalance may be involved.
4